upload —
wp_post_id: 28958
wp_status: future
scheduled_date: “2026-09-12T13:15:00”
scheduled_date_gmt: “2026-09-12T17:15:00”
uploaded: true
newsbreak_flag: true
featured_media: 28903
image_subject: “Laboratory”
image_provider: “wikimedia”
image_credit: “Rubbyfem – CC BY-SA 4.0/Wiki Commons”
image_source_url: “https://themoneyoverview.com/wp-content/uploads/2026/09/26-medicare-threw-157-laboratories-out-of-the-program-and-26.jpg”
image_media_id: 28903
image_reused_from_library: false
image_concept_matched: false
cross_site_checked: true
image_width: 1280
image_height: 720
—
Medicare stripped 157 laboratories of their billing privileges in a single enforcement action, a purge that federal officials say saved $732 million and forms the largest piece of more than $1.6 billion in fraudulent lab payments blocked since the start of the current administration. Inside that count sits one case that illustrates how far some operators pushed the scheme: a single individual enrolled 14 separate laboratories in Medicare’s fee-for-service system and billed more than $24 million for tests that could not have been performed, because investigators determined none of the 14 labs were actually operating.
The $1.6 Billion Breakdown: Revocations, Suspensions, and Recoupments
CMS broke down the full $1.6 billion into four categories in its press release: $732 million in savings from the 157 revoked lab providers; more than $500 million in potentially fraudulent payments halted through 185 payment suspensions tied to an investigation of 600 labs; more than $276 million recouped from 442 overpayments already paid out to suspect labs; and $127 million in potentially fraudulent payments prevented following 85 law enforcement referrals from a CMS contractor. Revocation is the most severe of those actions, permanently removing a provider’s ability to bill Medicare at all, while suspensions and recoupments target money already in motion or already paid.
CMS Administrator Dr. Mehmet Oz framed the effort as part of a broader campaign rather than a one-time sweep: “When laboratories bill Medicare for tests they never performed, it drains the Medicare Trust Fund and diverts resources away from beneficiaries who need them,” Oz said in the agency’s press release, adding that under the leadership of the White House Anti-Fraud Task Force, CMS has built a technology-powered fraud prevention operation to root out scammers across the health care system, from laboratory testing and hospice care to medical equipment and autism therapy.
Free retirement updates: A quiet rule change can shrink a Social Security or Medicare check, and no one sends a warning. The free Retirement Shield newsletter catches these early and explains what to do. Get it free.
How AI Flagged the Schemes: Three Case Studies
CMS credits artificial intelligence and machine-learning models with mining Medicare fee-for-service claims for unusual billing patterns, flagging suspicious claims so they can be held, rejected, or denied before any money goes out. The 14-lab case is the starkest example the agency published: the individual, who owned a consulting company rather than any lab directly, billed more than $24 million across the 14 enrollments. CMS suspensions are currently holding $12 million of that amount, roughly half of what the labs were paid in total, and the agency has separately recouped another $7 million. Eleven of the 14 Medicare enrollments have been revoked, with investigations continuing on the remaining three.
Two Texas labs suspected of billing for services never rendered show the system working at different speeds. One began billing at the end of February 2026 and had already drawn scrutiny by early April, when it shifted billing practices in an apparent attempt to work around CMS controls; the agency denied $1.2 million of its claims, a payment suspension caught another $150,000-plus in suspect payments, and the provider was revoked that same month. A second Texas lab tested the system with two days of claims in January and March before billing in earnest starting in May; CMS denied $1.9 million of its claims while a payment suspension captured an additional $1.7 million, and the provider remains under CMS review for revocation rather than already revoked.
A Pattern Extending Well Beyond Laboratory Testing
The lab crackdown is one piece of a larger enforcement push CMS says produced a “record-shattering $42 billion in savings in Fiscal Year 2025 alone.” So far in 2026, the agency has identified $1.8 billion in Medicare overpayments through medical review, collected $378 million in overpayments from post-payment reviews, and suspended more than $539 million in suspected fraudulent Medicare payments across all provider types, not laboratories alone. Fierce Healthcare’s reporting on the announcement placed the lab enforcement inside a wider pattern of aggressive CMS actions this year, including a $1.3 billion Medicaid funding deferral against California in May, which Oz called the largest such deferral the agency had ever made, and a combined $1.07 billion in Medicaid payment pauses against California and Minnesota in July.
Since January 1, 2026, CMS’s Fraud Defense Operations Center has separately accounted for more than $371 million in suspended Medicare payments involving 267 providers and suppliers, broken out as more than $226 million tied to suspect durable medical equipment billing, more than $53 million to suspect skin-substitute billing, and more than $23 million to suspect hospice providers. Laboratory testing is where the largest dollar figure landed this round, but CMS’s own accounting shows the same detection approach now running across durable medical equipment, hospice, and other categories of Medicare billing simultaneously.
CMS points beneficiaries and providers toward its own fraud-reporting resource page for more detail on how the agency is applying this enforcement approach across the program. The laboratory total is the largest single category disclosed in this announcement, but the agency’s broader FY2025 and 2026 figures suggest the fee-for-service claims mining behind the 157 revocations is now a standing operation rather than a one-time initiative aimed at a single type of provider.
Inside the kit
51 state Medicare cost-help packs, the new Part D out-of-pocket cap, the prior-authorization appeal steps and a medication and cost tracker.
The Medicare Cost & Coverage Protection Kit includes a 10-page kit, 51 state Medicare cost-help packs and the new Part D out-of-pocket cap.
Open The Medicare Cost & Coverage Protection Kit.
This article was researched and written with AI assistance and reviewed for accuracy against primary sources.
